Summary
Ovid Therapeutics
Founded in 2014
Description
This is Ovidwhere we are boldly transforming the lives of people affected by rare neurological diseases including Angelman syndrome, Fragile X syndrome and rare epilepsies.
Strengths
- There are no known strengths for Ovid Therapeutics
Weaknesses
- Ovid Therapeutics has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Since Ovid Therapeutics was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
Ovid Therapeutics's annual revenue
$1445000
Based on Kona Equity data
-
Revenue per employee
$29490
-
Annual revenue growth since founding
$144500
Employee Count
49 employees
Executives
Holly Roberts
Vice President, Medical Affairs
h**@ovidrx.comJeffrey Rona
Chief Business Officer & Chief Financial Officer
j**@ovidrx.comDirk Haasner
Global Senior VP, Regulatory Affairs, CMC & Quality Assurance
d**@ovidrx.comSuzanne Wakamoto
Senior VP, Human Resources
s**@ovidrx.comMasha Gorelik
Interim Controller
m**@ovidrx.comBina Keshavan
Head Vice President, Program Management
b**@ovidrx.comPeter Forgacs
Medical Director, Epilepsy
p**@ovidrx.comEmily Hu
Associate Director, Financial Planning & Analysis
e**@ovidrx.comBill Haddock
Vice President of Pharmacovigilance
b**@ovidrx.comRobert Morales
Senior VP, Accounting & Finance
r**@ovidrx.comMary Leuchars
Senior Medical Director, Clinical Development
m**@ovidrx.comG Score - 0
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
Location
Unlock unlimited leads
Similar Companies
Orphazyme
orphazyme.com- Founded in 2009
- Location: Copenhagen', None
- Annual Revenue: $5.1M
- Employees: 62
- Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients wit...
Inozyme Pharma Inc
inozyme.com- Founded in 2017
- Location: Boston, MA
- Annual Revenue: $14.7M
- Employees: 50
- Breakthrough Solutions at the Speed of Science.
Magenta Therapeutics, Inc.
magentatx.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $15.9M
- Employees: 86
- Magenta Therapeutics is a clinical-stage biotech developing therapeutics to curative power of stem cell transplants to more patients
Leap Therapeutics
leaptx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $1.1M
- Employees: 36
- Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Curemark LLC
curemark.com- Founded in 2006
- Location: Rye, NY
- Annual Revenue: $4.6M
- Employees: 16
- Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological and other disorders.
Key Information
- Name: Ovid Therapeutics
- Category: Biotechnology
- Industry: Pharmaceutical company
- SIC: 28; 283
- NAICS: 32; 325
See similar companies
-
By City New York City Small Pharmaceutical company in New York City Mid-size Pharmaceutical company in New York City Biotechnology in New York City Small Biotechnology in New York City Mid-size Biotechnology in New York City
-
By State NY Small companies in NY Biotechnology in NY Small Biotechnology in NY Mid-size Biotechnology in NY Small Pharmaceutical company in NY Mid-size Pharmaceutical company in NY
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Pharmaceutical company Small Pharmaceutical company Mid-size Pharmaceutical company Biotechnology and Pharmaceutical company
-
Firmographic data Founded in 2014 SIC: 28 SIC: 283 NAICS: 32 NAICS: 325 #Manufacturing #Pharmaceuticals
Frequently Asked Questions
Ovid Therapeutics's headquarters are located at 1460 Broadway New York City, NY 10036.
Ovid Therapeutics's official website is ovidrx.com
Ovid Therapeutics's annual revenue is $1.4 M.
Ovid Therapeutics's SIC: 28; 283
Ovid Therapeutics's NAICS: 32; 325.
Ovid Therapeutics has 49 employees
Ovid Therapeutics is in the industry of Biotechnology.
